| Primary |
| Gastrooesophageal Reflux Disease |
14.4% |
| Hypertension |
14.1% |
| Reflux Oesophagitis |
10.5% |
| Gastric Ulcer |
8.4% |
| Helicobacter Infection |
7.4% |
| Prophylaxis |
7.2% |
| Dyspepsia |
6.2% |
| Ill-defined Disorder |
5.3% |
| Duodenal Ulcer |
5.0% |
| Gastritis |
2.6% |
| Diabetes Mellitus |
2.4% |
| Back Pain |
2.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.2% |
| Cardiovascular Event Prophylaxis |
1.9% |
| Constipation |
1.9% |
| Drug Use For Unknown Indication |
1.9% |
| Dyslipidaemia |
1.9% |
| Diarrhoea |
1.7% |
| Gastric Disorder |
1.4% |
| Gastric Ulcer Haemorrhage |
1.4% |
|
| Hyponatraemia |
13.6% |
| Pancreatitis |
6.4% |
| Vomiting |
6.4% |
| Pneumonia |
5.6% |
| Pyrexia |
5.6% |
| Renal Failure |
5.6% |
| Renal Failure Acute |
5.6% |
| Renal Impairment |
5.6% |
| Interstitial Lung Disease |
4.8% |
| Malaise |
4.8% |
| Vision Blurred |
4.8% |
| Hepatic Function Abnormal |
4.0% |
| Liver Disorder |
4.0% |
| Tremor |
4.0% |
| Agranulocytosis |
3.2% |
| Cardiac Failure |
3.2% |
| Condition Aggravated |
3.2% |
| Gastrointestinal Haemorrhage |
3.2% |
| Haematoma |
3.2% |
| Lymphadenitis |
3.2% |
|
| Secondary |
| Product Used For Unknown Indication |
27.2% |
| Drug Use For Unknown Indication |
10.5% |
| Psoriatic Arthropathy |
8.5% |
| Hypertension |
7.9% |
| Prophylaxis |
7.2% |
| Rheumatoid Arthritis |
4.6% |
| Gastrooesophageal Reflux Disease |
3.6% |
| Helicobacter Infection |
3.4% |
| Duodenal Ulcer |
3.3% |
| Cardiac Failure |
2.9% |
| Insomnia |
2.8% |
| Gastric Ulcer |
2.7% |
| Constipation |
2.5% |
| Cardiac Failure Chronic |
2.2% |
| Cardiovascular Disorder |
2.0% |
| Antipyresis |
2.0% |
| Atrial Fibrillation |
2.0% |
| Diabetes Mellitus |
1.6% |
| Infection Prophylaxis |
1.6% |
| Pancreatitis Acute |
1.5% |
|
| Hypomagnesaemia |
8.5% |
| Interstitial Lung Disease |
8.5% |
| Liver Disorder |
8.5% |
| Tetany |
7.9% |
| Histiocytosis Haematophagic |
6.8% |
| Pancytopenia |
6.8% |
| Tubulointerstitial Nephritis |
6.2% |
| Renal Impairment |
5.1% |
| Vomiting |
5.1% |
| Urinary Retention |
4.5% |
| Pancreatitis Acute |
4.0% |
| Hyponatraemia |
3.4% |
| Infection |
3.4% |
| Pancreatitis |
3.4% |
| Platelet Count Decreased |
3.4% |
| Prostate Cancer |
3.4% |
| Asthma |
2.8% |
| Cerebral Infarction |
2.8% |
| Completed Suicide |
2.8% |
| Cytolytic Hepatitis |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.1% |
| Drug Use For Unknown Indication |
15.4% |
| Rheumatoid Arthritis |
13.9% |
| Prophylaxis |
11.8% |
| Hypertension |
8.0% |
| Hepatitis C |
3.7% |
| Pain |
3.0% |
| Multiple Myeloma |
2.7% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Osteoporosis |
2.6% |
| Crohn's Disease |
2.5% |
| Insomnia |
2.5% |
| Diabetes Mellitus |
2.5% |
| Constipation |
2.3% |
| Depression |
1.9% |
| Gastric Ulcer |
1.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.7% |
| Hiv Infection |
1.7% |
| Gastritis |
1.7% |
| Infection Prophylaxis |
1.4% |
|
| White Blood Cell Count Decreased |
10.7% |
| Vomiting |
9.8% |
| Interstitial Lung Disease |
7.1% |
| Pyrexia |
7.0% |
| Pneumonia |
6.5% |
| Platelet Count Decreased |
6.1% |
| Renal Impairment |
5.1% |
| Weight Decreased |
4.8% |
| Renal Failure Acute |
4.2% |
| Rash |
3.9% |
| Urinary Tract Infection |
3.8% |
| Anaemia |
3.8% |
| Death |
3.6% |
| Renal Failure |
3.5% |
| Hepatic Function Abnormal |
3.5% |
| Nausea |
3.5% |
| Weight Increased |
3.5% |
| Liver Disorder |
3.4% |
| Sepsis |
3.2% |
| White Blood Cell Count Increased |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
52.2% |
| Glaucoma |
8.7% |
| Osteoporosis |
8.7% |
| Smoking Cessation Therapy |
8.7% |
| Colitis |
4.3% |
| Colitis Ulcerative |
4.3% |
| Hypertension |
4.3% |
| Peptic Ulcer |
4.3% |
| Spondyloarthropathy |
4.3% |
|
| Drug Interaction |
16.7% |
| Drug Level Above Therapeutic |
16.7% |
| Gynaecomastia |
16.7% |
| Hallucination |
16.7% |
| Therapeutic Response Decreased |
16.7% |
| Thrombocytopenia |
16.7% |
|
